Inventor
Lixin Shao
Inventor
Wilmington, DE, US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds32%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry8%
A01NPreservation of bodies of humans or animals or plants or parts thereof3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
11,091,484Tricyclic heterocycles as BET protein inhibitors202111,091,491Heterocyclic compounds as PI3K-y inhibitors202111,078,204Heterocyclic derivatives as PI3K inhibitors202111,046,658Aminopyrazine derivatives as PI3K-g inhibitors202110,975,088Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors202110,738,057Tertiary alcohols as PI3K-g inhibitors202010,669,262Aminopyrazine diol compounds as PI3K-g inhibitors202010,640,506Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors202010,479,795Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors201910,472,368Heterocyclic compounds as PI3K-g inhibitors201910,442,803Tricyclic heterocycles as bet protein inhibitors201910,138,248Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-g inhibitors201810,065,963Heterocyclic compounds as PI3K-g inhibitors20189,777,003'Tricyclic heterocycles as bet protein inhibitors'20179,334,274'N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors'20169,309,246'Tricyclic heterocycles as BET protein inhibitors'20169,193,733'Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors'20158,933,085'Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors'20158,716,303'N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors'2014Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2014–2021Patents assigned to INCYTE CORP (19)· patent assignee history
2014–2015Patents assigned to GLENN JOSEPH (2)· patent assignee history
2014–2015Patents assigned to RODGERS JAMES D (2)· patent assignee history
2014–2015Patents assigned to SHAO LIXIN (2)· patent assignee history
2014–2016Based in Newark, DE, US· patent location history
2015–2020Patents assigned to INCYTE HOLDINGS CORP (3)· patent assignee history
2017–2021Based in Wilmington, DE, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INCYTE CORP | 19 | 2014–2021 |
| INCYTE HOLDINGS CORP | 3 | 2015–2020 |
| GLENN JOSEPH | 2 | 2014–2015 |
| RODGERS JAMES D | 2 | 2014–2015 |
| SHAO LIXINself | 2 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Wilmington, Delaware, US | 14 | 2017–2021 |
| Newark, Delaware, US | 5 | 2014–2016 |